Pentraxin 3 (PTX3) as a Predictor of Severity of Sepsis in Patients Admitted to an Intensive Care Unit

Abstract

Introduction – In the medical intensive care unit, sepsis is a prevalent clinical syndrome in critically ill patients. Numerous 
biomarkers and grading schemes are developed to identify adverse outcomes in sepsis patients. The purpose of this research is to 
determine if pentraxin 3 (PTX3) is a reliable predictor of sepsis in critically sick patients who have been hospitalized to intensive 
care units.